![]() Oxford Nanopore Technologies Oxford Nanopore Technologies is a company that develops nanopore-based electronic systems for the analysis of single molecules. | ![]() Pulse Biosciences Pulse Biosciences is a development-stage medical device company using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling or NPES. | ||
Founding Date | Founding Date 2014 | Founding Date 2005 | Founding Date 2014 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations San Francisco, US HQ | Locations Hayward, US HQ | |
Employees | Employees 842% increase | Employees 1,382 | Employees 8252% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.8 b | Valuation ($) 1 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) £223.9m (FY, 2025) | Revenue (est.) $350k (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods £42.8m (FY, 2025) | Cost of goods $539k (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit £181.1m (FY, 2025) | Gross profit ($189k) (FY, 2025) |
Net income | Net income N/A | Net income (£145.2m) (FY, 2025) | Net income ($72.8m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 96.4m | Total funding raised $ 1.3b | Total funding raised $ 300k |

Oxford Nanopore Technologies is a company that develops nanopore-based electronic systems for the analysis of single molecules.
View company
Pulse Biosciences is a development-stage medical device company using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling or NPES.
View company